Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications

Critical Reviews in Biotechnology

Volumn 36, Issue 6, 2016, Pages 1089-1098

  Gupta, Sanjeev K ^a,b   Shukla, Pratyoosh ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

^b IPCA Laboratories Ltd   (India)

Author keywords

Escherichia coli (E. coli); novel promoters; Pfenex system; pNEW vector; protein secretion; recombinant products

Indexed keywords

ANTIBODIES; CELL ENGINEERING; ENZYMES; ESCHERICHIA COLI; METABOLIC ENGINEERING; MONOCLONAL ANTIBODIES; PEPTIDES; PHYSIOLOGY; PROTEINS;

ESCHERICHIA COLI (E. COLI); NOVEL PROMOTERS; PFENEX SYSTEM; PROTEIN SECRETION; RECOMBINANT PRODUCTS;

RECOMBINANT PROTEINS;

BACTERIAL PROTEIN; CUMATE; LATE EMBRYOGENESIS ABUNDANT LIKE PEPTIDE; MONOCLONAL ANTIBODY; PFENEX PROTEIN; PROTEIN TAG; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; CHAPERONE; CODON; PEPTIDE;

BACTERIAL GENE; BIOENGINEERING; BIOTECHNOLOGY; CELL FREE SYSTEM; CELLULAR SECRETION; CODON; DISULFIDE BOND; ENHANCER REGION; ESCHERICHIA COLI; EXPRESSION VECTOR; FERMENTATION; GENE EXPRESSION SYSTEM; GLYCOENGINEERING; GLYCOSYLATION; HOST; METABOLIC ENGINEERING; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROMOTER REGION; REVIEW; GENETICS; HUMAN; METABOLISM; PROCEDURES;

CODON; ESCHERICHIA COLI; HUMANS; METABOLIC ENGINEERING; MOLECULAR CHAPERONES; PEPTIDES; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS;

EID: 84941762799     PISSN: 07388551     EISSN: 15497801     Source Type: Journal    
DOI: 10.3109/07388551.2015.1084264     Document Type: Review

References (73)

1. M.Akesson, P.Hagander, J.P.Axelsson. (2001). Probing control of fed-batch cultivations:analysis and tuning. Control Eng Pract, 9, 709–23
2. R.Assenberg, P.T.Wan, S.Geisse,. (2013). Advances in recombinant protein expression for use in pharmaceutical research. Curr Opin Struct Biol, 23, 393–402
3. F.Baneyx. (1999). Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol, 10, 411–21
4. B.Basar, M.Mohd-Shamzi. (2010). Enhanced production of thermophilic xylanase by recombinant Escherichia coli DH5α through optimization of medium and dissolved oxygen level. Int J Agri, 321–8
5. A.Berry. (1996). Improving production of aromatic compounds in Escherichia coli by metabolic engineering. Trends Biotechnol, 14, 250–6
6. J.Borrero, J.J.Jimenez, L.Gútiez,. (2011). Protein expression vector and secretion signal peptide optimization to drive the production, secretion, and functional expression of the bacteriocin enterocin A in lactic acid bacteria. J Biotechnol, 156, 76–86
7. P.M.Boyle, P.A.Silver. (2012). Parts plus pipes:synthetic biology approaches to metabolic engineering. Metab Eng, 14, 223–32
8. D.C.Cameron, N.E.Altaras, M.L.Hoffman,. (1998). Metabolic engineering of propanediol pathways. Biotechnol Prog, 14, 116–25
9. J.H.Choi, S.Y.Lee. (2004). Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol, 64, 625–35
10. Y.J.Choi, L.Morel, T.L.Francois. (2010). Novel, versatile, and tightly regulated expression system for Escherichia coli strains, Appl Environ Microbiol, 5058–66
11. C.Challener. (2015). Fermentation for the Future. BioPharm International, 28, 1
12. A.Correa, P.Oppezzo. (2015). Overcoming the solubility problem in E. coli:available approaches for recombinant protein production. Methods Mol Biol, 1258, 27–44
13. S.J.Costa, A.Almeida, A.Castro,. (2014). Fusion tags for protein solubility, purification, and immunogenicity in Escherichia coli:the novel Fh8 system. Front in Microbiol, 5, 63
14. S.Costa. (2013). Development of a novel fusion system for recombinant protein production and purification in Escherichia coli. Ph.D. Thesis, University of Minho, Braga, Portugal
15. S.J.Costa, A.Almeida, A.Castro,. (2013a). The novel Fh8 and H fusion partners for soluble protein expression in Escherichia coli:a comparison with the traditional gene fusion technology. Appl Microbiol Biotechnol, 97, 6779–91
16. S.J.Costa, E.Coelho, L.Franco,. (2013b). The Fh8 tag:a fusion partner for simple and cost-effective protein purification in Escherichia coli. Protein Expr Purif, 92, 163–70
17. A.De Marco. (2009). Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli. Microb Cell Fact, 8, 26
18. C.Elena, P.Ravasi, M.E.Castelli,. (2014). Expression of codon optimized genes in microbial systems:current industrial applications and perspectives. Front in Microbiol, 5, 21
19. D.Endy. (2005). Foundations for engineering biology. Nature, 438, 449–53
20. B.Fahnert, H.Lilie, P.Neubauer. (2004). Inclusion bodies:formation and utilisation. Adv Biochem Eng Biotechnol, 89, 93–142
21. M.Fakruddin, R.Mohammad Mazumdar, K.S.Bin Mannan,. (2013). Critical factors affecting the success of cloning, expression, and mass production of enzymes by recombinant E. coli. ISRN Biotechnol, 1–7
22. R.Fike. (2009). Nutrient supplementation strategies for biopharmaceutical production, Part 2:feeding for optimal recombinant protein production. BioProcess Int, 7, 46–52
23. A.Frenzel, M.Michael Hust, T.Thomas Schirrmann. (2013). Expression of recombinant antibodies:Front in Immunol, 4, 217
24. G.L.Rosano, E.A.Ceccarelli. (2014). Recombinant protein expression in Escherichia coli:advances and challenges. Front in Microbiol, 4, 217
25. M.N.Gonzalez, F.E.GarcIa, S.Ventura,. (2006). Comparative analysis of E. coli inclusion bodies and thermal protein aggregates. Microb Cell Fact, 5
26. S.Graslund,. (2008). Protein production and purification. Nat Methods, 5, 135–46
27. M.Heinemann, S.Panke. (2006). Synthetic biology-putting engineering into biology. Bioinform, 22, 2790–99
28. C.J.Huang, H.Lin, X.Yang. (2012). Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J Ind Microbiol Biotechnol, 39, 383–99
29. P.M.Hwang, J.P.Pan, B.D.Sykes. (2014). Targeted expression, purification, and cleavage of fusion proteins from inclusion bodies in Escherichia coli. FEBS Lett, 588, 247–52. http://dx.doi.org/10.1016/j.febslet.2013.09.028
30. S.Ikeno, T.Haruyama. (2013). Boost protein expression through co-expression of LEA-like peptide in Escherichia coli. PLoS One 8(12), e82824
31. S.Jana, J.K.Deb. (2005). Strategies for efficient production of heterologous proteins in Escherichia coli. Appl Microbiol Biotechnol, 67, 289–98
32. H.Z.Jaliani, S.Farajnia, Y.Safdari,. (2014). Optimized condition for enhanced soluble expression of recombinant mutant Anabaena variabilis phenylalanine ammonia lyase. Adv Pharma Bulle, 4, 261–6
33. S.Jevsevar, V.Gaberc-Porekar, I.Fonda. (2005). Production of nonclassical inclusion bodies from which correctly folded protein can be extracted. Biotechnol Prog, 21, 632–39
34. E.Jordan, L.Al-Halabi, T.Schirrmann,. (2007). Production of single chain Fab (scFab) fragments in Bacillus megaterium. Microb Cell Fact, 6, 38
35. M.A.Jonet, N.M.Mahadi, A.M.Abdul Murad,. (2012). Optimization of heterologous signal peptide by site-directed mutagenesis for improved secretion of recombinant proteins in Escheichia coli. J Mol Microbiol Biotechnol, 22, 48–58
36. M.Kesik-Brodacka, A.Romanik, D.M.Sygula, G.Plucienniczak, A.Plucienniczak. (2012). A novel system for stable, high level protein expression from the T7 promoter. Microb Cell Fact, 11, 109
37. O.Khow, S.Suntrarachun. (2012). Strategies for production of active eukaryotic proteins in bacterial expression system. Asian Pac J Trop Biomed, 159–62
38. W.Kim, H.Erlandsen, S.Surendran, et al. (2004). Trends in enzyme therapy for phenylketonuria. Mol Ther, 10, 220–4
39. S.Klatt, Z.Konthur. (2012). Secretory signal peptide modification for optimized antibody-fragment expression-secretion in Leishmania tarentolae. Microb Cell Fact, 11, 97
40. M.Koffas, L.Roberge, K.Lee,. (1999). Metabolic engineering. Annu Rev of Biomed Eng, 1, 535–57
41. J.W.Lamppaa, S.A.Tanyosa, K.E.Griswolda. (2013). Engineering Escherichia coli for soluble expression and single step purification of active human lysozyme. J Biotechnol, 164, 1–8. http://dx.doi.org/10.1016/j.jbiotec.2012.11.007
42. E.Leonard, D.Nielsen, K.Solomon,. (2008). Engineering microbes with synthetic biology frameworks. Trends Biotechnol, 26, 674–81
43. J.F.Li, X.W.Cui, H.Y.Ji,. (2011). High efficient expression of bioactive human BMP-14 in E. coli using SUMO fusion partner. Protein J, 30, 592–97
44. R.McDaniel, R.Weiss. (2005). Advances in synthetic biology:on the path from prototypes to applications. Curr Opin Biotechnol, 16, 476–83
45. H.Merk, C.Gless, B.Maertens,. (2012). Cell-free synthesis of functional and endotoxin-free antibody Fab fragments by translocation into microsomes. BioTechniq, 53, 153–60
46. H.Meng, J.Wang, Z.Xiong,. (2013). Quantitative design of regulatory elements based on high-precision strength prediction using artificial neural network. PLoS One, 8, e60288
47. M.Merdanovic, T.Clausen, M.Kaiser,. (2011). Protein quality control in the bacterial periplasm. Annu Rev Microbiol, 65, 149–68
48. H.P.Meyer, C.Leist, A.Fiechter. (1984). Acetate formation in continuous culture of E. coli K12 D1 on defined and complex media. J Biotechnol, 1, 355–8
49. T.S.Miguel, P.P.Bermúdez, I.Gavidia. (2013). Production of soluble eukaryotic Recombinant proteins in E. coli is favoured in early log-phase cultures induced at low temperature. Springer Plus, 2, 89
50. S.Mondal, D.Shet, C.Prasanna, et al. (2013). High yield expression of proteins in E. coli for NMR studies. Adv Biosci Biotechnol, 751–67
51. R.F.Ohana, L.P.Encell, K.Zhao,. (2009). HaloTag7:a genetically engineered tag that enhances bacterial expression of soluble proteins and proves protein purification. Protein Expr Purif, 68, 110–20
52. Purohit MK, Singh SP. (2013). A metagenomic alkaline protease from saline habitat:Cloning, over-expression and functional attributes. Int J Biol Macromol, 53, 138–43. http://dx.doi.org/10.1016/j.ijbiomac.2012.10.032
53. D.Retallack, R.Coleman. (2011). Achieving optimal expression for Fabs. GEN, Tuto, 31, 13
54. P.Rohe, D.Venkanna, B.Kleine, (2012). An automated workflow for enhancing microbial bioprocess optimization on a novel microbioreactor platform. Microbial Cell Fact, 11, 144
55. G.L.Rosano, E.A.Ceccarelli. (2014). Recombinant protein expression in Escherichia coli:advances and challenges. Front in Microbiol, 5, 172
56. M.Satakarni, R.Curtis. (2011). Production of recombinant peptides as fusions with SUMO. Protein Expr Purif, 78,113–19
57. T.Satyanarayana, Thermophiles. (2007). Curr Sci, 93, 1340–2
58. T.San-Miguel, P.Pérez-Bermúdez, I.Gavidia. (2013). Production of soluble eukaryotic recombinant proteins in E. coli is favoured in early log-phase cultures induced at low temperature. SpringerPlus, 2, 89
59. I.Seyis, N.Aksoz. (2005). Effect of carbon and nitrogen sources on xylanase production by Trichoderma harzianum 1073 D3. Int Biodet Biodeg, 55, 115–19
60. E.Shiue, K.L.J.Prather. (2012). Synthetic biology devices as tools for metabolic engineering. Biochem Eng, 65, 82–9
61. S.Schlegel, E.Rujas, A.J.Ytterberg, et al. (2013). Optimizing heterologous protein production in the periplasm of E. coli by regulating gene expression levels. Microb Cell Fact, 12, 24
62. S.Shrivastava, P.Shukla, K.Mukhopadhyay. (2011). Purification and preliminary characterization of a xylanase from Thermomyces lanuginosus strain SS-8. Biotech, 1, 255–9
63. S.Shrivastava, P.Shukla, P.D.Deepalakshmi,. (2013). Characterization, cloning and functional expression of novel xylanase from Thermomyces lanuginosus SS-8 isolated from self-heating plant wreckage material. World J Microb Biot, 12, 2407–15
64. O.Spadiut, S.Capone, F.Krainer, et al.(2014). Microbials for the production of monoclonal antibodies and antibody fragments. Trends in Biotechnology, 32, 1
65. F.W.Studier. (2014). Stable expression clones and auto-induction for protein production in E. coli. Methods Mol Biol, 1091, 17–32
66. J.R.Swartz. (2001). Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol, 12, 195–201
67. N.K.Tripathi, A.Shrivastva, K.C.Biswal,. (2009). Optimization of culture medium for production of recombinant dengue protein in Escherichia coli. Ind Biotechnol, 5(3)
68. J.D.Valderrama-rincon, A.C.Fisher, J.H.Merritt,. (2012). NIH Public Access, 8, 434–36
69. G.P.Voulgaridou, T.Mantso, K.Chlichlia, et al. (2013). Efficient E. coli expression strategies for production of soluble human crystallin ALDH3A1. PLoS One, 8, e56582
70. A.G.Wacker Chemic, S.Leonhatsberger, Jena,. (2012). Signal peptide for the production of recombinant proteins. US 8148494 B2
71. M.Wacker, D.Linton, P.G.Hitchen,. (2002). N-linked glycosylation in Campylobactor jejuni and its functional transfer into E. coli. Science, 298, 1790–3
72. L.Yee, H.W.Blanch. (1992). Recombinant protein expression in high cell density fed-batch cultures of Escherichia coli. Biotechnology, 10, 1150–56
73. S.Zerbs, S.Giuliani, F.Collart. (2014). Small-scale expression of proteins in E. coli. Methods Enzymol, 536, 117–31